Is näky's NAD⁺ really $185 a month?

Only if you pay for a year in advance. The month-to-month price is $195, which näky states in parentheses on the same line as the $185. A three-month supply is $555, which also works out to $185 a month — so the quarterly plan already captures the entire discount.

Is the annual plan worth it?

On these numbers, no. Twelve months at $185 is $2,220 against $2,340 paid monthly, a saving of $120. The three-month plan gets you the same $185 rate for a quarter of the commitment. Unless something about annual billing suits you specifically, there is no pricing reason to take it.

How many milligrams per injection?

The page does not say, anywhere. There is no concentration, no vial volume and no per-injection milligram figure, only that the injection is weekly. That matters more than it sounds: it means $195 cannot be set against a competitor charging $197 for a disclosed 1200 mg, because you have no idea whether you are buying the same amount, half as much, or twice.

What does "same price at every dose" mean?

Näky uses it as a promise that your cost will not rise if a provider increases your dose, which is a genuinely useful commitment in a category where GLP-1 sellers routinely charge by strength. The difficulty is that no dose is published, so there is no starting point the promise is measured from.

Is compounded NAD⁺ FDA-approved?

No. Näky's own fine print says compounded medications have not been evaluated or approved by the FDA for safety, efficacy or quality, and that is right. The header badge about FDA-regulated pharmacies describes the facility, not the drug — registration and inspection of a pharmacy is not approval of what it compounds.

Is Näky expensive compared with other NAD⁺ injection providers providers?

Näky publishes a starting figure of $195/mo. Across the 116 NAD⁺ injection providers providers we review that publish a single monthly figure, those run $17.97 to $799 with a median of $175, which puts Näky above the median. The other 33 NAD⁺ injection providers providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Updated September 2026

Näky review

Annual headline, monthly truth

A weekly NAD⁺ injection whose advertised rate is an annual prepay — and whose annual plan costs exactly what three months costs.

Our verdict

Näky leads with $185 a month and, to its credit, tells you on the same line that the real month-to-month rate is $195. Take the $195. The $185 requires paying for a full year up front, and the three-month plan already gets you to $185 — so twelve months of commitment buys nothing the quarter did not. The bigger problem is that no milligram figure appears anywhere on the page, which leaves a header badge promising the same price at every dose with no dose to attach it to.

Disclosure: NAD Picks is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Check availability →

At a glance

Category: NAD⁺ injections
Format: Injection
From: $195/mo
Dose published: No
Prescription: Required
Compounded: Yes — not FDA-approved
Pharmacy: Not named
Updated: September 2026

What it is

A cash-pay telehealth brand selling compounded NAD⁺ as a weekly subcutaneous injection, with sermorelin as the other longevity product. The larger business is weight loss — compounded tirzepatide and semaglutide, an oral semaglutide, a branded tablet and a microdosed GLP-1 protocol.

How it works

A three-minute online assessment for provisional approval, then a licensed provider builds a treatment plan, described as same-day. Medication is compounded by US-based, state-licensed 503A pharmacies — which prepare each order against a prescription — working to USP sterile compounding standards and shipped with free delivery; näky states pharmacy processing takes two to four business days with three to five days in transit. There is no in-person visit and no insurance involved, and the page states the service is not available in every state without listing which.

Pricing transparency

The month-to-month price is $195. A three-month supply is $555, which is $185 a month, and the annual plan is also $185 a month — delivered monthly or quarterly but paid for a year at a time. That means the only discount on offer is $10 a month, worth $120 across a year, and you capture all of it by committing for three months rather than twelve. The headline on the page is the $185, with the $195 disclosed in parentheses immediately after it. That disclosure is more than several competitors manage, but the number in large type is still the one you cannot get without prepaying.

Branded vs compounded

Compounded NAD⁺. The fine print states that compounded medications have not been evaluated or approved by the FDA for safety, efficacy or quality, which is the correct framing — compounded drugs are made by a licensed pharmacy against an individual prescription and are never reviewed by the FDA before dispensing. Note the tension with a header badge advertising FDA-regulated pharmacies: a pharmacy can be registered and inspected while the compounded drug it prepares remains outside FDA approval. No milligram dose, concentration or vial volume is published, so there is no quantity behind the price.

Pros and watch-outs

What we like

Discloses the month-to-month rate on the same line as the advertised annual one
$195 month to month is competitive against most compounded injection plans
Publishes a plain plan list — one month $195, three months $555 — rather than hiding tiers behind an intake
Names 503A pharmacies and USP sterile compounding standards
States that compounded medications are not FDA-evaluated
Free shipping and a stated fulfillment timeline

Watch-outs

The advertised $185 is an annual prepay; month to month is $195
The annual plan costs the same per month as the three-month plan, so the extra nine months of commitment buys nothing
No milligram dose anywhere — which leaves the "same price at every dose" badge impossible to check
An FDA-regulated pharmacies badge sits above a compounded product that is not FDA-approved
The NAD⁺ product page opens its FAQ with five questions about sermorelin
The safety paragraph contains two misspellings in the sentence about prescriptions
Says it is not available in all states without naming them

Best for

A buyer who wants a straightforward weekly injection at a mid-market monthly price and has no interest in prepaying for a year to save ten dollars a month.

Who should look elsewhere

Anyone who needs to know how much NAD⁺ is in the syringe. Without a milligram figure, $195 cannot be weighed against a seller publishing 1000 or 1200 mg for a similar amount.

How Näky compares

A few alternatives worth a look, depending on what you’re optimizing for.

Care Bare Rx
Anyone who wants the price up front
See Care Bare Rx →
Breeze Meds
The lowest listed injection price
See Breeze Meds →
CoreAge Rx
The lowest published NAD⁺ price
See CoreAge Rx →

Compare all providers side by side →

More NAD⁺ injection providers reviews: Qualia NAD+Life Extension NAD+ Cell RegeneratorElysium BasisRenue By ScienceWonderfeel YoungrProHealth Longevity

Michael Reyes

Cost & access · Reviewed and last verified September 2026

How we assessed this. This review reflects NAD Picks’s own read of Näky’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

Is näky's NAD⁺ really $185 a month?: Only if you pay for a year in advance. The month-to-month price is $195, which näky states in parentheses on the same line as the $185. A three-month supply is $555, which also works out to $185 a month — so the quarterly plan already captures the entire discount.
Is the annual plan worth it?: On these numbers, no. Twelve months at $185 is $2,220 against $2,340 paid monthly, a saving of $120. The three-month plan gets you the same $185 rate for a quarter of the commitment. Unless something about annual billing suits you specifically, there is no pricing reason to take it.
How many milligrams per injection?: The page does not say, anywhere. There is no concentration, no vial volume and no per-injection milligram figure, only that the injection is weekly. That matters more than it sounds: it means $195 cannot be set against a competitor charging $197 for a disclosed 1200 mg, because you have no idea whether you are buying the same amount, half as much, or twice.
What does "same price at every dose" mean?: Näky uses it as a promise that your cost will not rise if a provider increases your dose, which is a genuinely useful commitment in a category where GLP-1 sellers routinely charge by strength. The difficulty is that no dose is published, so there is no starting point the promise is measured from.
Is compounded NAD⁺ FDA-approved?: No. Näky's own fine print says compounded medications have not been evaluated or approved by the FDA for safety, efficacy or quality, and that is right. The header badge about FDA-regulated pharmacies describes the facility, not the drug — registration and inspection of a pharmacy is not approval of what it compounds.
Is Näky expensive compared with other NAD⁺ injection providers providers?: Näky publishes a starting figure of $195/mo. Across the 116 NAD⁺ injection providers providers we review that publish a single monthly figure, those run $17.97 to $799 with a median of $175, which puts Näky above the median. The other 33 NAD⁺ injection providers providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Check availability →

Or compare every NAD⁺ injection provider.